Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 380,834 | 418,175 | 368,872 | 397,039 | 382,421 |
| Cost of Goods | 180,596 | 192,258 | 162,038 | 170,546 | 164,076 |
| Gross Profit | 200,238 | 225,917 | 206,834 | 226,493 | 218,345 |
| Operating Expenses | 208,984 | 229,204 | 202,908 | 190,992 | 191,828 |
| Operating Income | -8,150 | -3,029 | 3,964 | 36,047 | 26,593 |
| Interest Expense | 19,373 | 18,651 | 13,624 | 13,751 | 13,062 |
| Other Income | 7,161 | 6,495 | 4,430 | 6,562 | 5,078 |
| Pre-tax Income | -20,362 | -15,185 | -5,230 | 28,858 | 18,609 |
| Income Tax | -9,667 | -2,783 | -1,949 | 9,024 | -888 |
| Net Income Continuous | -10,695 | -12,402 | -3,281 | 19,834 | 19,497 |
| Net Income | $-10,695 | $-12,402 | $-3,281 | $19,834 | $19,497 |
| EPS Basic Total Ops | -0.14 | -0.16 | -0.04 | 0.26 | 0.24 |
| EPS Basic Continuous Ops | -0.14 | -0.16 | -0.04 | 0.25 | 0.24 |
| EPS Diluted Total Ops | -0.14 | -0.16 | -0.04 | 0.26 | 0.24 |
| EPS Diluted Continuous Ops | -0.14 | -0.16 | -0.04 | 0.25 | 0.24 |
| EPS Diluted Before Non-Recurring Items | 0.41 | 0.63 | 0.55 | N/A | N/A |
| EBITDA(a) | $29,146 | $35,208 | $35,928 | $68,465 | $58,568 |